The National Centre for Asbestos Related Diseases (NCARD) is proud to release its 2024 Annual Report.
This year’s report highlights our research achievements, including:
-
Discovery of blood biomarkers that can predict mesothelioma treatment response, bringing personalised medicine closer to reality.
-
Launch of the Collaborative Centre for Innovative Pleural Research and advances in imaging, RNA vaccines, and childhood cancer projects.
-
Recognition of our researchers and students through prestigious awards, national appointments, and strong international collaborations.
-
Continued commitment to training the next generation of scientists and engaging with patients, families, and the wider community.
The report also reflects on the legacy of Robert Vojakovic AM JP, founder of the Asbestos Diseases Society of Australia, whose lifelong advocacy inspires our mission to improve outcomes for people affected by asbestos-related diseases.
